Late infections following allogeneic bone marrow transplantation: Suggested strategies for prophylaxis

References

• Ochs L., Shu X. O., Miller J., Enright H., Wagner J., Filipovich A., Miller W., Weisdorf D. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3979–3986
   PubMed Web of Science ®Google Scholar
• Hoyle C., Goldman J. M. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplantation 1994; 14: 247–252
   PubMed Web of Science ®Google Scholar
• Atkinson K., Storb R., Prentice R. L., Weiden P. L., Sullivan K. M., Witherspoon R. P., Noel D., Thomas E. D. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720–731
   PubMed Web of Science ®Google Scholar
• Atkinson K., Farewell V., Storb R., Tsoi M., Sullivan K. M., Witherspoon R. P., Fefer A., Clift R., Goodell B., Thomas E. D. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982; 60: 714–720
   PubMed Web of Science ®Google Scholar
• Paulin T., Ringden O., Nilsson B., Lonnqvist B., Gohrton G. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987; 43: 393–398
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Mori M., Sanders J., Siadak M., Witherspoon R. P., Anasetti C., Applebaum F. R., Bensinger W., Bowden R., Buckner C. D., Clark J., Crawford S., Deeg H. J., Doney K., Flowers M., Hansen J., Loughran T., Martin P., McDonald G., Pepe M., Petersen F. B., Scheuning F., Stewart P., Storb R. Late complications of allogeneic and autologous marrow transplantation. Bane Marrow Transplantation 1992; 10 suppl 1: 127–134
   PubMed Web of Science ®Google Scholar
• Zimmerli W., Zarth A., Gratwohl A., Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991; 77: 393–399
   PubMed Web of Science ®Google Scholar
• Al-Eid M. A., Tutschka P. J., Wagner H. N. J., Santos G. W., Tsan M. F. Functional asplenia in patients with chronic graft-versus-host disease: Concise communication. Journal of Nuclear Medicine 1983; 24: 1123
   PubMed Web of Science ®Google Scholar
• Kahls P., Panzer S., Kletter K., Minar E., Stain-Kos M., Walter R., Lechner K., Hinterberger W. Functional asplenia after bone marrow transplantation: a late complication related to extensive chronic graft-versus-host disease. Annals of Internal Medicine 1988; 109: 461–464
   PubMed Web of Science ®Google Scholar
• Sable C. A., Donowitz G. R. Infections in bone marrow transplant recipients. Clinical Infectious Diseases 1994; 18: 273–284
   PubMed Web of Science ®Google Scholar
• Marks D. I., Cullis J. O., Ward K. M., Lacey S., Szydlo R., Hughes T. P., Schwarer A. P., Lutz E., Barret A. J., Hows J. M., Batchelor R., Goldman J. M. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Annals of Internal Medicine 1993; 119: 207–214
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Agura E., Anasetti C., Bearman B. S., Erickson K., Flowers M., Hansen J., Loughran T., Martin P., Matthews D., Petersdorf E., Radich J., Riddell S., Rovira D., Sanders J., Scheuning F., Siadak M., Storb R., Witherspoon R. P. Chronic graft-versus-host dis-ease and other late complications of bone marrow transplantation. Seminars in Hematology 1991; 28: 250–259
   PubMed Web of Science ®Google Scholar
• Gale R., Opelz G., Mickey M. R., Graze P. R., Saxon A. Immunodeficiency following allogeneic bone marrow transplantation. Transplantation Proceedings 1978; 10: 223–235
   PubMed Web of Science ®Google Scholar
• Elfenbein G. J., Anderson P. N., Humphrey R. L., Mullins G. M., Sensenbrenner L., Wands J. R., Santos G. W. Immune system reconstitution following allogeneic bone marrow transplantation in man. A multiparameter analysis. Transplantation Proceedings 1976; 8: 641–646
   PubMed Web of Science ®Google Scholar
• Atkinson K. Reconstitution of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplantation 1990; 5: 209–226
   PubMed Web of Science ®Google Scholar
• Atkinson K., Luckhurst E., Penny R., Warren H., Biggs J. Immunologic reconstitution after allogeneic marrow transplantation in man. Transplantation Proceedings 1983; 15: 474–479
   Web of Science ®Google Scholar
• Witherspoon R. P., Lum L. G., Storb R. Immunological reconstitution after human marrow grafting. Seminars in Hematology 1984; 21: 2–10
   PubMed Web of Science ®Google Scholar
• Paulin T., Ringden O., Nilsson B. Immunological recovery after bone marrow transplantation: Role of age, graft-versus-host disease, prednisolone treatment and infections. Bone Marrow Transplantation 1987; 1: 317–328
   PubMed Web of Science ®Google Scholar
• Lum L. G., Orcutt-Thordarson N., Seigneuret M. C., Storb R. The regulation of Ig synthesis after marrow transplantation IV. T4 and T8 subset function in patients with chronic graft-versus-host disease. Journal of Immunology 1982; 129: 113–119
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Storb R., Oachs H. D., Flournoy N., Kopecky K. J., Sullivan K. M., Deeg J. H., Sosa R., Noel D. R., Atkinson K., Thomas E. D. Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time post transplantation, the presence or absence of graft versus host disease, and anti-thymocyte globulin treatment. Blood 1981; 58: 360–368
   PubMed Web of Science ®Google Scholar
• Territo M. C., Gale R. P., Cline M. J. Neutrophil function in bone marrow transplant recipients. British Journal of Haematology 1977; 35: 245–250
   PubMed Web of Science ®Google Scholar
• Sosa R., Weiden P. L., Storb R., Syrotuck J., Thomas E. D. Granulocyte function in human allogeneic marrow graft recipients. Experimental Hematology 1980; 8: 1183–1189
   PubMed Web of Science ®Google Scholar
• Friedrich W., O'Reilly R. J., Koziner B., Gebhard D. F., Good R. A., Evans R. L. T-lymphocyte reconstitution in recipients of bone marrow transplants with and with-out GVHD: Imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood 1982; 59: 696–701
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Matthews D., Storb R., Atkinson K., Cheever M., Deeg H. J., Doney K., Kalbfleisch J., Noel D., Prentice R., Sullivan K. M., Thomas E. D. Recovery of in vivo cellular immunity after human marrow grafting. Influence of time post-grafting and acute graft-versus-host disease. Transplantation 1984; 37: 145–150
   PubMed Web of Science ®Google Scholar
• Tsoi M. S., Storb R., Dobbs S., Kopecky K. J., Santos E., Weiden P. L., Thomas E. D. Nonspecific sup-pressor cells in patients with chronic graft-versus-host disease after marrow grafting. Journal of Immunology 1979; 123: 1970–1976
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Lum L. G., Storb R., Thomas E. D. In vitro regulation of immunoglobulin synthesis after human transplantation. H. Deficient T and non-T lymphocyte function within 3–4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy. Blood 1982; 59: 844–850
   PubMed Web of Science ®Google Scholar
• Aucouturier P., Barra A., Intrator L., Cordonnier C., Schulz D., Durate F., Vernant J. P., Pred'homme J. L. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70: 779–785
   PubMed Web of Science ®Google Scholar
• Abedi M. R., Hammarstrom L., Ringden O., Edvard-Smith C. I. Development of IgA deficiency after bone marrow transplantation. Transplantation 1990; 50: 415–421
   PubMed Web of Science ®Google Scholar
• Lum L. G. The kinetics of immune reconstitution after human marrow transplant. Blood 1987; 69: 369–380
   PubMed Web of Science ®Google Scholar
• Lum L. G., Noges J. E., Beatty P., Martin P. J., Deeg J., Dooney K. C., Loughram T., Sullivan K. M., Witherspoon R. P., Thomas E. D., Storb R. Transfer of specific immunity in marrow recipients given HLA mismatched, T cell depleted or HLA identical marrow grafts. Bone Marrow Transplantation 1988; 3: 339–406
   PubMedGoogle Scholar
• Clark J. G., Crawford S., Madtes D. K., Sullivan K. M. Obstructive lung disease after allogeneic marrow transplantation. Annals of Internal Medicine 1989; 111: 368–376
   PubMed Web of Science ®Google Scholar
• Han C. S., Miller W., Haake R., Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplantation 1994; 13: 277–283
   PubMed Web of Science ®Google Scholar
• Locksley R. M., Flournoy N., Sullivan K. M., Meyers J. D. Infection with varicella-zoster virus after marrow transplantation. Journal of Infectious Diseases 1985; 152: 1172–1181
   PubMed Web of Science ®Google Scholar
• Hertz M. I., Englund J. A., Snover D., Bitterman P. B., McGlave P. Respiratory syncitial virus-induced acute lung injury in adult patients with bone marrow transplantation: a clinical approach and review of literature. Medicine 1989; 68: 269–281
   PubMed Web of Science ®Google Scholar
• Wendt C. H., Weisdorf D. J., Jordan M. C., Balfour H. H., Hertz M. I. Parainfluenza virus respiratory infection after bone marrow transplantation. New England Journal of Medicine 1992; 326: 921–926
   PubMed Web of Science ®Google Scholar
• Apperley J. F., Rice S. J., Bishop J. A., Chia Y. C., Krausz T., Gardner S. D., Goldman J. M. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomavirus after bone marrow transplantation. Transplantation 1987; 43: 108–112
   PubMed Web of Science ®Google Scholar
• Shields A. F., Hackman R. F., Fife K. H., Corey K., Meyers J. D. Adenovirus in patients undergoing bone marrow transplantation. New England Journal of Medicine 1985; 312: 529–533
   PubMed Web of Science ®Google Scholar
• Verfaillie C., Weisdorf D., Haake R., Hostetter M., Ramsay N. K. C., McGlave P. Candida infections in bone marrow transplant recipients. Bone Marrow Transplantation 1991; 8: 177–184
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Mellits E. D., Sostrin M. B., Chen D. Y., Burns W. H., Santos G. W., Vriesendorp H. M., Beschorner W. E., Saral R. Interstitial pneumonitis after allogeneic bone marrow transplantation. Medicine 1988; 67: 175–186
   PubMed Web of Science ®Google Scholar
• Krowka M. J., Rosenow E. C., Hoagland H. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237–246
   PubMed Web of Science ®Google Scholar
• Tuan I. Z., Dennison D., Weisdorf D. J. Pneomocystis carinii pneumonitis following bone marrow transplant. Bone Marrow Transplantation 1992; 10: 267–272
   PubMedGoogle Scholar
• Sullivan K. M., Dahlberg S., Storb R., et al. Infection prophylaxis with chronic graft-versus-host disease. Experimental Hematology 1983; 11: ???193
   PubMedGoogle Scholar
• Bowden R. A., Slichter S. J., Sayers M., Weisdorf D., Cays M., Schoch G., Banaji M., Haake R., Welk K., Fisher L., McCullough J., Miller W. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86: 3598–3603
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Reed E. C., Shepp D. H., Thornquist M., Dandiker P. S., Vicary C. A., Flournoy N., Kirk L. E., Kersey J. H., Thomas E. D., Balfour H. H. Acyclovir for the prevention of cytomegalovirus infection and disease after bone marrow transplantation. New England Journal of Medicine 1988; 318: 70–75
   PubMed Web of Science ®Google Scholar
• Prentice H. G., Gluckman E., Powles R. L., Ljungman P., Milpied N., Fernandez Ranada J. M., Mandelli F., Kennedy L., Bell A. R. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. (European Acyclovir for CMV Prophylaxis Study Group). Lancet 1994; 343: 749–753
   PubMed Web of Science ®Google Scholar
• Winston D. J., Ho W. G., Bartoni K., Du Mond C., Ebeling D. F., Buhles W. C., Champlin R. E. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Annals of Internal Medicine 1993; 118: 179–184
   PubMed Web of Science ®Google Scholar
• Goodrich J. M., Bowden R. A., Fisher L., Keller C., Schoch G., Meyers J. D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after bone marrow transplant. Annals of Internal Medicine 1993; 118: 173–178
   PubMed Web of Science ®Google Scholar
• Atkinson K., Downs K., Golenia M., Biggs J., Marshall G., Dodds A., Concannon A. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: Absence of clinical cytomegalovirus infection. British Journal of Haematology 1991; 79: 57–62
   PubMed Web of Science ®Google Scholar
• Reusser P., Gambertoglio J. G., Lilleby K., Meyers J. D. Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic mar-row transplant recipients. Journal of Infectious Diseases 1992; 163: 473–479
   Google Scholar
• Shepp D. H., Dandliker P. S., Meyers J. Treatment of Vericalla-zoster infection in severely immunocompromized patients. A randomized comparison of acyclovir and vidarabine. New England Journal of Medicine 1986; 314: 208–212
   PubMed Web of Science ®Google Scholar
• Hughes W. T., Rivera G. K., Schnell M. J., Thornton D., Lott D. Successful intermittent chemoprophylaxis for pneumocystis carinii pneumonitis. New England Journal of Medicine 1987; 316: 1627–1632
   PubMed Web of Science ®Google Scholar
• Olsen S., Renlund D. G., O'Connell J. B., Taylor D. O., Lasseter J. E., Eastburn T. E., Hammond E. H., Bristow M. R. Prevention of pneumocystis pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 1993; 56: 359–362
   PubMed Web of Science ®Google Scholar
• Leoung G. S., Feigal D. W. J., Montgomery A. B., Corkery K., Wardlaw L., Adams M., Busch D., Dordon D., Jacobson M. A., Volberding P. A., Abrams D. Aerosolized pentamidine for prophylaxis against pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. New England Journal of Medicine 1990; 323: 769–775
   PubMed Web of Science ®Google Scholar
• Goodman J. L., Winston D. J., Greenfield R. A., Chandrasekar P. H., Fox B., Kaizer H., Shadduck R. K., Shea T. C., Stiff P., Friedman D. J., Powderly W. G., Silber J. L., Horowitz H., Lichtin A., Wolff S. N., Mangan K. F., Silver S. M., Weisdorf D., Ho W. G., Gilbert G., Buell D. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 1992; 326: 835–851
   PubMed Web of Science ®Google Scholar
• Alangaden G., Chandrashekar P. H., Bailey E., Khaliq Y., Bone Marrow Transplantation Team. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. Bone Marrow Transplantation 1994; 14: 919–924
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated with fluconazole. New England Journal of Medicine 1991; 325: 1274–1277
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Miller C. B., Karp J. E., Sara] R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrobial Agents & Chemotherapy 1993; 37: 1847–1849
   PubMed Web of Science ®Google Scholar
• Peterson F. B., Bowden R. A., Thornquist M., et al. The effect of prophylactic immunoglobulin on the incidence of septicemia in marrow transplant recipients. Bone Marrow Transplantation 1987; 2: 141–148
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Kopecky K. J., Jacom J., Fisher L., Buckner C. D., Meyers J. D., Counts G. W., Bowden R. A., Petersen F. B., Witherspoon R. P., Budinger M. D., Schwartz R. S., Applebaum F. R., Clift R. A., Hansen J. A., Sanders J. E., Thomas D. E., Storb R. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New England Journal of Medicine 1990; 323: 705–712
   PubMed Web of Science ®Google Scholar
• Graham-Pole J., Casper C. J., Elfenbein G., Gross S., Herzig R., Koch P., Mahoney D., Marcus R., Munoz L., Pick T., Spruce W., Steuber P., Weiner R. Intravenous immunoglobulin may lesson all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. Bone Marrow Transplantation 1988; 3: 559–566
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Kopecky K., Witherspoon R. P., et al. Intravenous immunoglobulin (IVIg) for prevention of late infections after bone marrow transplantation (BMT) (abstract). Experimental Hematology 1990; 18: 689
   Google Scholar
• Sullivan K. M., Storek J., Kopecky K. J., Jacom J., Longston G., Flowers M., Siadak M., Nims J., Witherspoon R. P., Anasetti C., Applebaum F. R., Bowden R. A., Buckner C. D., Crawford S. W., Deeg H. J., Hansen J. A., McDonald G. B., Sanders J. E., Storb R. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infections and chronic graftversus-host disease after bone marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biology of blood and Marrow Transplantation 1996; 2: 44–53
   PubMedGoogle Scholar
• Copelan E. A., Betchel T. P., Klein J. P., Klein J. L., Tutschka P., Kapoor N., Featheringham N. C., Avalos B. R. Controlled trial of orally administered immunoglobulin following bone marrow transplantation. Bone Marrow Transplantation 1994; 13: 87–91
   PubMed Web of Science ®Google Scholar
• Giebink G. S., Warkentin P. I., Ramsay N. K. C., Kersey J. H. Titer of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. Journal of Infectious Diseases 1986; 154: 590–596
   PubMed Web of Science ®Google Scholar
• Winston D. J., Winston G. H., Schiffman G., Champlin R. E., Feig S. A., Gale R. P. Pneumococcal vaccination of recipients of bone marrow transplantation. Archives of Internal Medicine 1983; 143: 1735–1737
   PubMed Web of Science ®Google Scholar
• Barra A., Cordonnier C., Preziosi M. P., Intrator L., Hesse] L., Fritzell B., Preud'homme J. L. Immunogenecity of Haemophilus influenzae type b conjugate vaccine an allogeneic bone marrow recipients. Journal of Infectious Diseases 1992; 166: 1201–1208
   PubMedGoogle Scholar
• Robbins J. B., Schneerson R. Polysaccharide-protein conjugates: A new generation of vaccines. Journal of Infectious Diseases 1990; 161: 821–832
   PubMed Web of Science ®Google Scholar
• Gardener P., Schaffner W. Immunization of adults. New England Journal of Medicine 1993; 328: 1252–1258
   PubMed Web of Science ®Google Scholar
• Engelhard D., Nagler A., Hardan I., Morag A., Aker M., Baciu H., Strauss N., Parag G., Naparstek E., Ravid Z., Or R., Slavin S., Zakay-Rones Z. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplantation 1993; 11: 1–5
   PubMed Web of Science ®Google Scholar
• Yeung C. Y., Liang D. C. Varicella vaccine in children with acute iymphoblastic leukemia and non-hodgkin lymphoma. Pediatric Hematology and Oncology 1992; 9: 29–34
   PubMed Web of Science ®Google Scholar
• Diaz P. S., Au D., Smith S., Amylon M., Link M., Smith S., Arvin A. M. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their sibling. Pediatrics 1991; 87: 166–170
   PubMed Web of Science ®Google Scholar
• Ljungman P., Wicklund-Hammarsten M., Duraj V., Hammarstrom L., Lonnqvist B., Paulin T., Ringden O., Pepe M. S., Gahrton G. Response to tetanus toxoid immunization after allogeneic bone marrow transplant. Journal of Infectious Diseases 1990; 162: 496–500
   PubMed Web of Science ®Google Scholar
• Ljungman P., Duraj V., Magnius L. Response to immunization against polio after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1991; 7: 89–93
   PubMed Web of Science ®Google Scholar
• Ljungman P., Fridell E., Lonnqvist B., Bolme P., Bottiger M., Gahrton G., Linde A., Ringden O., Wahren B. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Journal of Infectious Diseases 1989; 159: 610–615
   PubMed Web of Science ®Google Scholar
• Somani J., Larson R. A. Reimmunization after allogeneic bone marrow transplantation. American Journal of Medicine 1995; 98: 389–398
   PubMed Web of Science ®Google Scholar
• Molrine D. C., Guinan E. C., Antin J. H., Parsons S. K., Weinstein H. J., Wheeler C., McGarigle C., Blanding P., Phillips N. R., Kinsella K., Deans K., Ciamarra A., Goorin A., George S., Ambrosino M. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012–3018
   PubMed Web of Science ®Google Scholar
• Gottlieb D. J., Cryz S. J., Furer E., Que J. U., Prentice H. G., Duncombe A. S., Brenner M. K. Immunity against Pseudomonas aerogenosa adoptively transferred to bone marrow transplant recipients. Blood 1990; 76: 2470–2475
   PubMed Web of Science ®Google Scholar